This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms
joint with Genetic and Molecular Basis of Obesity and Body Weight Regulation
Organizer(s): Alan D. Attie, Christopher B. Newgard and Philipp E. Scherer
Date: January 29 - February 03, 2012
Location: Santa Fe Community Convention Center, Santa Fe, NM, USA
Sponsored by Pfizer Inc. and MedImmune
Summary of Meeting:
This meeting will focus on genetic, epigenetic and biochemical mechanisms underlying the pathogenesis of diabetes. New methods, particularly proteomics and the ability to interrogate protein modifications (phosphorylation, acetylation, methylation) on a large scale, are providing a new window into the pathological processes in type 2 diabetes. Other emerging themes are the CNS control of metabolism, the role of the microbiome in regulating metabolism, and transdifferentiation of cells in the endocrine pancreas in the adaptive response to obesity and insulin resistance. The strength of this meeting lies in the interdisciplinary nature of these topics. Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms is held jointly with a the Keystone Symposia meeting on Genetic and Molecular Basis of Obesity and Body Weight Regulation, an obvious match with any conference devoted to type 2 diabetes; for example, adipose tissue function is dramatically changed in obesity, and adipocytes and adipose tissue immune cells produce proteins that modulate insulin signaling.
Scholarship Deadline: September 29 2011
Discounted Abstract Deadline: September 29 2011
Abstract Deadline: November 1 2011
Discounted Registration Deadline: November 29 2011
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
MedImmunePfizer Inc.
We gratefully acknowledge additional support for this conference from:
CEDARLANECell Signaling Technology, Inc.
Journal of Lipid Research
Mercodia, Inc.Novartis Institutes for BioMedical ResearchSeahorse Bioscience, Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Bristol-Myers Squibb Company

Eli Lilly and Company

Metabolic Solutions Development Company, LLC.


Marc Prentki
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 5R13DK084688-03
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found